Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,256 | 18,520 | 23,192 | 19,420 | 23,421 |
| TOTAL | $12,902 | $18,924 | $24,041 | $20,644 | $25,268 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $12,902 | $18,924 | $24,041 | $20,644 | $25,268 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,861 | 3,520 | 2,348 | 2,553 | 1,426 |
| Accrued Expenses | 3,032 | 6,143 | 1,228 | 1,924 | 2,198 |
| TOTAL | $6,560 | $9,962 | $3,576 | $4,477 | $3,624 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 556 | 567 | 106 | 106 | 284 |
| TOTAL | $556 | $567 | $106 | $106 | $284 |
| Total Liabilities | $7,117 | $10,529 | $3,681 | $4,583 | $3,907 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,635 | 20,452 | 20,443 | 18,133 | 15,133 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -97,774 | -95,093 | -83,053 | -79,538 | -74,197 |
| TOTAL | $5,785 | $8,394 | $20,360 | $16,060 | $21,361 |
| Total Liabilities And Equity | $12,902 | $18,924 | $24,041 | $20,644 | $25,268 |